Krishna Ella, Ph.D., is the founder, chairman and managing director of Bharat Biotech International Limited.
After early education in agricultural sciences, Ella studied at the University of Hawaii and the University of Wisconsin-Madison. Following a brief stint as a research faculty at the Medical University of South Carolina-Charleston, he returned to India and set up Bharat Biotech International Limited, a multidimensional biotechnology company specializing in R&D, manufacturing and marketing of vaccines and biotherapeutics for human use. Today, Bharat Biotech is one of the leading innovative R&D Companies, with 45 global patents, of which five are for new molecules.
Ella’s scientific expertise is in gene knock-out and expression systems. As an entrepreneur with over two decades of experience in product development and manufacturing, he has recently ventured into other areas like veterinary vaccines (Biovet), food processing (Innova Agri Bio), functional foods (Century Biologicals), contract research services (RCC Labs) and developing biotechnology infrastructure (Konark Bio Park).
He has received several awards for his academic recognitions, including the Rotary Fellowship, and the National Research Service Award of the U.S. National Institutes of Health. He also has been honoured for his entrepreneurial skills with awards such as the J.R.D. TATA – Best Entrepreneur of the Year and Marico Innovation award received from the Prime Minister of India, among several others.
Ella is a member, adviror or chair of numerous committees that shape India’s science education, policy and international collaboration. These include the Five Year Plan for Biotechnology, Human Resource and Innovation; National Biotech Policy, High Technology Cooperation Groups; the National Task Force in Industrial Biotechnology, and the National Council of IPR. He has recently been nominated as a member of the Scientific Advisory Committee to the Prime Minister of India